Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects
Status:
Completed
Trial end date:
2011-11-22
Target enrollment:
Participant gender:
Summary
This trial was conducted in Asia. The aim of this trial was to investigate the
pharmacokinetic properties (the effect of the investigated drug on the body) of NN1250
(insulin degludec) in healthy Chinese subjects.